Variation in the RAD51 gene and familial breast cancer

Breast Cancer Research

Volumn 8, Issue 3, 2006, Pages

  Lose, Felicity ^a,b   Lovelock, Paul ^a,b   Chenevix Trench, Georgia ^a   Mann, Graham J ^c   Pupo, Gulietta M ^c   Spurdle, Amanda B ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; BRCA1 PROTEIN; BRCA2 PROTEIN; DOUBLE STRANDED DNA; GUANINE; RAD51 PROTEIN; RECA PROTEIN; RAD51 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DNA DAMAGE; DNA REPAIR; EMBRYO DEATH; EUKARYOTE; EXON; FAMILIAL CANCER; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC PREDISPOSITION; GENETIC RECOMBINATION; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HETEROZYGOSITY LOSS; HUMAN; INTRON; LETHALITY; LYMPHOBLASTOID CELL LINE; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROTEIN PROTEIN INTERACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; ADULT; BREAST TUMOR; CASE CONTROL STUDY; FEMALE; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ONSET AGE; PEDIGREE; TUMOR CELL CULTURE;

ADULT; AGE OF ONSET; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PEDIGREE; RAD51 RECOMBINASE; TUMOR CELLS, CULTURED;

EID: 33744974573     PISSN: 1465542X     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr1415     Document Type: Article

References (34)

1. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, et al.: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998, 62:676-689.
2. Sidransky D, Tokino T, Helzlsouer K, Zehnbauer B, Rausch G, Shelton B, Prestigiacomo L, Vogelstein B, Davidson N: Inherited p53 gene mutations in breast cancer. Cancer Res 1992, 52:2984-2986.
3. Lynch ED, Ostermeyer EA, Lee MK, Arena JF, Ji H, Dann J, Swisshelm K, Suchard D, MacLeod PM, Kvinnsland S, et al.: Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis. Am J Hum Genet 1997, 61:1254-1260.
4. Chenevix-Trench G, Spurdle AB, Gatei M, Kelly H, Marsh A, Chen X, Donn K, Cummings M, Nyholt D, Jenkins MA, et al.: Dominant negative ATM mutations in breast cancer families. J Natl Cancer Inst 2002, 94:205-215.
5. *1100delC allelic variant and risk of breast cancer: screening results from the Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev 2006, 15:348-352.
6. Khanna KK, Jackson SP: DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 2001, 27:247-254.
7. Benson FE, Stasiak A, West SC: Purification and characterization of the human Rad51 protein, an analogue of E. coli RecA. Embo J 1994, 13:5764-5771.
8. Shinohara A, Ogawa H, Matsuda Y, Ushio N, Ikeo K, Ogawa T: Cloning of human, mouse and fission yeast recombination genes homologous to RAD51 and recA. Nat Genet 1993, 4:239-243.
9. Richardson C: RAD51, genomic stability, and tumorigenesis. Cancer Lett 2005, 218:127-139.
10. Tsuzuki T, Fujii Y, Sakumi K, Tominaga Y, Nakao K, Sekiguchi M, Matsushiro A, Yoshimura Y, Morita T: Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc Natl Acad Sci USA 1996, 93:6236-6240.
11. Takahashi E, Matsuda Y, Hori T, Yasuda N, Tsuji S, Mori M, Yoshimura Y, Yamamoto A, Morita T, Matsushiro A: Chromosome mapping of the human (RECA) and mouse (Reca) homologs of the yeast RAD51 and Escherichia coli recA genes to human (15q15.1) and mouse (2F1) chromosomes by direct R-banding fluorescence in situ hybridization. Genomics 1994, 19:376-378.
12. Wick W, Petersen I, Schmutzler RK, Wolfarth B, Lenartz D, Bierhoff E, Hummerich J, Muller DJ, Stangl AP, Schramm J, et al.: Evidence for a novel tumor suppressor gene on chromosome 15 associated with progression to a metastatic stage in breast cancer. Oncogene 1996, 12:973-978.
13. Gonzalez R, Silva JM, Dominguez G, Garcia JM, Martinez G, Vargas J, Provencio M, Espana P, Bonilla F: Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations. Br J Cancer 1999, 81:503-509.
14. Hedenfalk I, Ringner M, Ben-Dor A, Yakhini Z, Chen Y, Chebil G, Ach R, Loman N, Olsson H, Meltzer P, et al.: Molecular classification of familial non-BRCA1/BRCA2 breast cancer. Proc Natl Acad Sci USA 2003, 100:2532-2537.
15. Yoshikawa K, Ogawa T, Baer R, Hemmi H, Honda K, Yamauchi A, Inamoto T, Ko K, Yazumi S, Motoda H, et al.: Abnormal expression of BRCA1 and BRCA1-interactive DNA-repair proteins in breast carcinomas. Int J Cancer 2000, 88:28-36.
16. Ma XJ, Salunga R, Tuggle JT, Gaudet J, Enright E, McQuary P, Payette T, Pistone M, Stecker K, Zhang BM, et al.: Gene expression profiles of human breast cancer progression. Proc Natl Acad Sci USA 2003, 100:5974-5979.
17. Maacke H, Opitz S, Jost K, Hamdorf W, Henning W, Kruger S, Feller AC, Lopens A, Diedrich K, Schwinger E, Strurzbecher HW: Over-expression of wild-type Rad51 correlates with histological grading of invasive ductal breast cancer. Int J Cancer 2000, 88:907-913.
18. Raderschall E, Stout K, Freier S, Suckow V, Schweiger S, Haaf T: Elevated levels of Rad51 recombination protein in tumor cells. Cancer Res 2002, 62:219-225.
19. Baumann P, West SC: The human Rad51 protein: polarity of strand transfer and stimulation by hRP-A. EMBO J 1997, 16:5198-5206.
20. Thacker J: The RAD51 gene family, genetic instability and cancer. Cancer Lett 2005, 219:125-135.
21. Bell DW, Wahrer DC, Kang DH, MacMahon MS, FitzGerald MG, Ishioka C, Isselbacher KJ, Krainer M, Haber DA: Common nonsense mutations in RAD52. Cancer Res 1999, 59:3883-3888.
22. Kato M, Yano K, Matsuo F, Saito H, Katagiri T, Kurumizaka H, Yoshimoto M, Kasumi F, Akiyama F, Sakamoto G, et al.: Identification of Rad51 alteration in patients with bilateral breast cancer. J Hum Genet 2000, 45:133-137.
23. Rapakko K, Heikkinen K, Karppinen SM, Winqvist R: Screening for RAD51 and BRCA2 BRC repeat mutations in breast and ovarian cancer families. Cancer Lett 2005, 236:142-147.
24. Eng C, Brody LC, Wagner TM, Devilee P, Vijg J, Szabo C, Tavtigian SV, Nathanson KL, Ostrander E, Frank TS: Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1. J Med Genet 2001, 38:824-833.
25. Jones AC, Austin J, Hansen N, Hoogendoorn B, Oefner PJ, Cheadle JP, O'Donovan MC: Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis. Clin Chem 1999, 45:1133-1140.
26. Mann GJ, Thorne H, Balleine RL, Butow PN, Clarke CL, Edkins E, Evans GM, Fereday S, Haan E, Gattas M, et al.: Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res 2006, 8:R12.
27. Heath AC, Bucholz KK, Madden PA, Dinwiddie SH, Slutske WS, Bierut LJ, Statham DJ, Dunne MP, Whitfield JB, Martin NG: Genetic and environmental contributions to alcohol dependence risk in a national twin sample: consistency of findings in women and men. Psychol Med 1997, 27:1381-1396.
28. Primer3 [http://cbr-rbc.nrc-cnrc.gc.ca/cgi-bin/primer3_www.cgi]
29. DHPLC Melt program [http://insertion.stanford.edu/melt.html]
30. Singer-Sam J, LeBon JM, Dai A, Riggs AD: A sensitive, quantitative assay for measurement of allele-specific transcripts differing by a single nucleotide. PCR Methods Appl 1992, 1:160-163.
31. Schwartz S, Zhang Z, Frazer KA, Smit A, Riemer C, Bouck J, Gibbs R, Hardison R, Miller W: PipMaker - a web server for aligning two genomic DNA sequences. Genome Res 2000, 10:577-586.
32. Alex Dong Li's SpliceSiteFinder [http://www.genet.sickkids.on.ca/~ali/ splicesitefinder.html]
33. Schmutte C, Tombline G, Rhiem K, Sadoff MM, Schmutzler R, von Deimling A, Fishel R: Characterization of the human Rad51 genomic locus and examination of tumors with 15q14-15 loss of heterozygosity (LOH). Cancer Res 1999, 59:4564-4569.
34. NCBI Entrez SNP database [http://www.ncbi.nlm.nih.gov/projects/SNP/]